Founder and CEO @ Nanjing AscendRare Pharmaceutical Technology Co (October 2018 - Present)
Associate Director @ Nanjing Institute of Advanced Biotechnology and Life Science (October 2018 - April 2021)
Research Assistant Professor @ (January 2010 - September 2018)
Scientist @ (May 2003 - December 2009)
Postdoctoral Fellowship @ Children's Hospital of Philadelphia @ University of Pennsylvania (June 2000 - April 2003)
Changhong Li Education
Peking University (Beijing Medical University)
MD. (Ph.D, Internal Medicine, Endocrinology)
1991-1996
Changhong Li Skills
Pharmaceutics
Molecular Biology
islet
biochemistry
endocrinology
Diabetes
insulin secretion
生命科学
生物化学
细胞生物学
细胞培养
分子生物学
临床研究
研究
生物技术
Rare Diseases
糖尿病
Biopharmaceuticals
Medicine
Science
Changhong Li Summary
Changhong Li, based in China, is currently a Chief Scientific Officer at Hua Medicine. Changhong Li brings experience from previous roles at Nanjing AscendRare Pharmaceutical Technology Co, Nanjing Institute of Advanced Biotechnology and Life Science and Children's Hospital of Philadelphia. Changhong Li holds a 1991 - 1996 MD. in Ph.D, Internal Medicine, Endocrinology @ Peking University (Beijing Medical University). With a robust skill set that includes Pharmaceutics, Molecular Biology, islet, biochemistry, endocrinology and more. Changhong Li has 1 emails on RocketReach.
Looking for a different Changhong Li?
Find contact details for 700 million professionals.